medigraphic.com
ISSN 1025-0255 (Electronic)

2022, Number 1

<< Back Next >>

AMC 2022; 26 (1)

Clinical, endoscopic and histological characterization of inflammatory bowel disease

Toledo-Cabarcos Y, Marrero-Rodríguez S

Language: Spanish
References: 30
Page:
PDF size: 841.13 Kb.


ABSTRACT

Introduction: Inflammatory bowel disease is a chronic disease of multifactorial etiology that in recent years has increased the number of diagnosed cases, so the clinical-endoscopic and histopathological approach is of vital importance to provide comprehensive care to patients.
Objective: To characterize the inflammatory bowel disease clinical-endoscopic and histopathologically.
Methods: A cross-sectional observational study was carried out. The universe was composed of 78 patients diagnosed with inflammatory bowel disease and the sample was made up of 54 patients. The data obtained from biopsy ballots were collected in a form.
Results: Patients aged between 50 and 69 years old predominated. Female sex and white skin color prevailed. The cardinal symptom that predominated was diarrhea followed by enterorrhagia and the time of evolution that prevailed was 4 to 6 months. The most frequent location of the lesions was the left colon and ulcerative colitis predominated as the main variant. Continuous lesions and granular appearance of the mucosa predominated in endoscopic features, while in histological features crypt distortion and inflammatory infiltrate of the same layer prevailed. Among the complications, the fistula stood out and most of these patients required surgical treatment.
Conclusions: Greater affectation in middle ages, female and white skin color patients. The main associated symptom is diarrhea. The most common variant was ulcerative colitis. Adequate clinical-endoscopic and histopathological correlation was evidenced. The main complication was the fistulous tracts and intestinal stenosis, that mostly require surgical treatment.


REFERENCES

  1. Hano García OM, Estupiñán Sosa MF, la Rosa Hernández D, González Fabián L. Respuesta inmunitaria humoral en pacientes con Colitis Ulcerosa. Rev cuban invest bioméd [Internet]. 2016 Jul-Sep [citado 15 Ene 2022];35(3). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-03002016000300002 1.

  2. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoffet G, et al. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology [Internet]. 2012 Ene [citado 17 Ene 2022];142(1):46-54. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/22001864/ 2.

  3. Figueroa C. Epidemiología de la enfermedad inflamatoria intestinal. Rev Méd Clín Condes[Internet]. 2019 Jul-Ago [citado 09 Mar 2020];30(4):257-61. Disponible en: Disponible en: https://www.elsevier.es/es-revista-revista-medica-clinica-las-condes-202-articulo-epidemiologia-enfermedad-inflamatoria-intestinal-S0716864019300562 3.

  4. Kotze PG, Steinwurz F, Francisconi C, Zaltman C, Pinheiro M, Salese L, et al. Review of the epidemiology and burden of ulcerative colitis in Latin America. Therap Adv Gastroenterol[Internet]. 2020 [citado 12 May 2021];13. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350039/ 4.

  5. Carbonnel F, Soularue E, Coutzac C, Chaput N, Mateus C, Lepage P, et al. Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora? In Seminars in immunopathology [Internet]. 2017 Abr [citado 17 Ene 2022];39(3):327-31. Disponible en: https://link.springer.com/article/10.1007/s00281-016-0613-x5.

  6. Harusato A, Abo H, Ngo VL, Yi SW, Mitsutake K, Osuka S, et al. IL-36y signaling controls the induced regulatory T cell-Th9 cell balance via NFkB activation and STAT transcription factors. Mucosal Inmunol [Internet]. 2017 Nov [citado 17 Ene 2018];10(6):1455-67. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5610052/ 6.

  7. Sexton KA, Walker JR, Graff LA, Bernstein MT, Beatie B, Miller N, et al. Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease. Inflamm Bowel Dis [Internet]. 2017 Mar [citado 17 Ene 2022];23(3):473-83. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28221251/ 7.

  8. Higashiyama M, Sugita A, Koganei K, Wanatabe K, Yokoyama Y, Uchino M, et al. Management of elderly ulcerative colitis in Japan. J Gastroenterol [Internet]. 2019 [citado 17 Ene 2022];54(7):571-86. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685935/ 8.

  9. Schreiner P, Biedermann L, Rossel JB, Rogler G, Pittet V, von Känel R, et al. Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis [Internet]. 2017 Feb [citado 17 Ene 2022];23(2):310-17. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28079622/ 9.

  10. Franken Morales SS, García Orrego AM. Guía diagnóstica y terapéutica de la enfermedad inflamatoria intestinal. Rev méd sinerg [Internet]. 2021 Sep[citado 23 de May 2022];6(9):e713. Disponible en: Disponible en: https://revistamedicasinergia.com/index.php/rms/article/view/713 10.

  11. López Calleja AM, Cano Sanz N. Guía Práctica de Enfermería en Enfermedad Inflamatoria Intestinal [Internet]. Madrid: Abbvie; 2017 [citado 09 Mar 2022]. Disponible en: Disponible en: https://www.geteii.com/wp-content/uploads/2017/10/GUIA-DE-ENFERMERIA-EII-ULTIMA-REVISIO%CC%81N.pdf 11.

  12. Vavricka SR, Gubler M, Gantenbein C, Spoerri M, Froehlich F, Seibold F, et al. Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study. Inflamm Bowel Dis [Internet]. 2017 Jul [citado 17 Ene 2022];23(7):1174-81. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28452862/ 12.

  13. Glassner K, Malaty HM, Abraham BP. Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis [Internet]. 2017 Jun [citado 17 Ene 2022];23(6):998-1003. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28511199/ 13.

  14. Kammerlander H, Nielsen J, Kjeldsen J, Knudsen T, Friedman S, Nørgård B. The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease. Inflamm Bowel Dis [Internet]. 2017 Jun [citado 17 Ene 2022];23(6):1011-18. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/28346274/ 14.

  15. Fernández Maqueira G, Crespo Ramírez E, González Pérez S, Jerez Marimón D, García Capote E. Colitis ulcerosa, una mirada por dentro. Rev cienc méd Pinar Río [Internet]. 2018 [citado 20 Ene 2022];22(3). Disponible en: Disponible en: http://www.revcmpinar.sld.cu/index.php/publicaciones/article/view/3391/html 15.

  16. Paredes Méndez J, Otoya Moreno G, Mestanza Rivas Plata AL, Lazo Molina L, Acuña Ordoñez K, Arenas Gamio JL, et al. Características epidemiológicas y clínicas de la enfermedad inflamatoria intestinal en un hospital de referencia de Lima-Perú. Rev gastroenterol Perú [Internet]. 2016 Jul-Sep[citado 17 Mar 2020];36(3). Disponible en: Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1022-51292016000300004 16.

  17. Sambuelli AM, Negreira S, Gil A, Goncalves S, Chavero P, Tirado P, et al. Manejo de la enfermedad inflamatoria intestinal. Revisión y algoritmos de tratamiento. Acta Gastroenterol Latinoam [Internet]. 2019 [citado 21 Feb 2020];49(Suppl 2). Disponible en: Disponible en: https://www.actagastro.org/numeros-anteriores/2019/Vol-49-S2/Vol49S2.pdf 17.

  18. López Roldán G, Alba López C, Taxonera C. Diagnóstico y Tratamiento de la Enfermedad Inflamatoria Intestinal en 2022. An RANM [Internet]. 2022 [citado 12 May 2022];139(01):31-35. Disponible en: Disponible en: https://analesranm.es/wp-content/uploads/2022/numero_139_01/pdfs/ar13901-doc01.pdf 18.

  19. Kappelman MD, Rifas-Shiman SL, Kleinman K, Ollendorf D, Bousvaros A, Grand RJ, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol [Internet]. 2007 Dic [citado 12 May 2022];5(12):1424-9. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/17904915/ 19.

  20. Bernklev T, Huppertz-Hauss G, Opheim R, Henriksen M, Lie Høivik ML, Moum B, et al. P-048 Co-Existing IBS in Inflammatory Bowel Disease (IBD) Is Associated with Increased Risk of Chronic Fatigue (CF), Especially in Females. Inflamm Bowel Dis [Internet]. 2017 Feb [citado 17 Ene 2022];23(Suppl 1):S20-S21. Disponible en: Disponible en: https://academic.oup.com/ibdjournal/article/23/suppl_1/S20/4561215 20.

  21. Iade B, Buenavida GB, Casañas A. Incidence of inflammatory bowel disease in two medical centers in Uruguay, during the period 2007-2011. Acta Gastroenterol Latinoam [Internet]. 2018 [citado 21 Feb 2020];48(4):263-70. Disponible en: Disponible en: https://www.redalyc.org/journal/1993/199359103003/html/ 21.

  22. Betteridge JD, Armbruster SP, Maydonovitch C, Veerappan GR. Inflammatory bowel disease prevalence by age, gender, race, and geographic location in the U.S. military health care population. Inflamm Bowel Dis [Internet]. 2013 Jun[citado 09 Mar 2020];19(7):1421-7. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/23518811/ 22.

  23. Selvaratnam S, Gullino S, Shim L, Lee E, Lee A, Paramsothy S, et al. Epidemiology of inflammatory bowel disease in South America: A systematic review. World J Gastroenterol [Internet]. 2019 Dic[citado 09 Mar 2020];25(47):6866-75. Disponible en: Disponible en: https://pubmed.ncbi.nlm.nih.gov/31885427/ 23.

  24. Salazar González M, Furet Rodríguez EM, Díaz Fondén J, Navarro Nápoles J, Alvarado Reyes YA. Factores de riesgo asociados a la enfermedad inflamatoria intestinal en ancianos. Medisan[Internet]. 2020 Ene-Feb[citado 14 Mar 2022];24(1). Disponible en: Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192020000100088 24.

  25. Simian D, Estay C, Lubascher J, Acuña R, Kronberg U, Figueroa C, et al. Enfermedad inflamatoria intestinal a partir de una experiencia local. Rev méd Chile [Internet]. 2014 Ago[citado 18 Mar 2020];142(8). Disponible en: Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872014000800008 25.

  26. Muñoz F, Ripollés T, Poza Cordón J, de las Heras Páez de la Cadena B, Martínez-Pérez MJ, de Miguel E, et al. Recommendations of the Spanish Working Group on Crohn´s Disease and Ulcerative Colitis (GETECCU) on the use of abdominal ultrasound in inflammatory bowel disease. Gastroenterol Hepatol [Internet]. 2021 Feb [citado 23 May 2022];44(2):158-174. Disponible en: Disponible en: https://www.elsevier.es/en-revista-gastroenterologia-hepatologia-english-edition--382-articulo-recommendations-spanish-working-group-on-S2444382421000420 26.

  27. Cervantes-Peláez D, Rojas- Peláez Y, Osorio-Cárdenas A, Alpizar-Quesada O, Reyes-Escobar AD, Smith-López E. Comportamiento de las enfermedades inflamatorias del intestino en el Servicio Provincial de Coloproctología de Camagüey. Arch méd Camagüey [Internet]. 2021 [citado 23 May 2022];25(4). Disponible en: Disponible en: http://revistaamc.sld.cu/index.php/amc/article/view/8000/4069 27.

  28. Juliao-Baños F, Puentes F, López R, Saffon MA, Reyes G, Parra V, et al. Characterization of inflammatory bowel disease in Colombia: Results of a national register. Rev Gastroenterol Méx [Internet]. 2021 Abr-Jun [citado 14 May 2022];86(2):153-62. Disponible en: Disponible en: http://www.revistagastroenterologiamexico.org/en-characterization-inflammatory-bowel-disease-in-articulo-S2255534X21000207 28.

  29. Ripollés T, Muñoz F, Martínez-Pérez MJ, de Miguel E, Poza Cordón J, de las Heras Páez de la Cadena B. Usefulness of intestinal ultrasound in inflammatory bowel disease. Radiologia. 2021 Ene-Feb; 63(1): 89-102. doi.org/10.1016/j.rx.2020.10.001.

  30. La Rosa Hernández D, Sánchez Castañeda N, Vega Sánchez H. Una mirada actualizada a la patogenia de la enfermedad inflamatoria intestinal. Arch cuba gastroenterol [Internet]. 2020 [citado 20 May 2021];1(3). Disponible en: Disponible en: http://revgastro.sld.cu/index.php/gast/article/view/54/151 30.




2020     |     www.medigraphic.com